Antibiotics and Tissue Expanders in Breast Reconstruction

• Status: Withdrawn
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study is a randomized controlled non-blinded double arm study examining the effect of routine postoperative oral antibiotic therapy in preventing postoperative surgical site infections after breast reconstruction. The investigators hypothesize that use of prophylactic antibiotics after breast reconstruction does not reduce surgical site infections.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Emory University
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cephalexin; Clindamycin

Criteria

Inclusion Criteria:

• Patients in whom implant-based breast reconstruction is selected based on clinician recommendation, patient agreement, and mutual consensus.

• Ability to understand the purposes and risks of the study and willingly give standard written informed consent for treatment established by Emory University Hospital and affiliates.

Exclusion Criteria:

• Pregnancy

• Incarceration

• Non-implant based reconstructive plan

• Any condition that, in the opinion of the attending physician, would place the patient at undue risk by participating.